Education
About Us
Working with TipRanks
Follow Us
Eurofins-Cerep SA (FR:ALECR)
:ALECR
ALECR Stock Chart & Stats
€17800.00
€0.00(0.00%)
At close: 4:00 PM EST
€17800.00
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€10,000.00 - €26,800.00
Previous CloseN/A
Volume1.00
Average Volume (3M)0.00
Market Cap
€89.80M
Enterprise Value€95.87M
Total Cash (Recent Filing)€13.65M
Total Debt (Recent Filing)€70.00K
Price to Earnings (P/E)14.6
Beta0.05
Next Earnings
Apr 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)360.82
Shares Outstanding5,045
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-2.18
Price to Book (P/B)1.38
Price to Sales (P/S)2.44
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Eurofins-Cerep SA News
ALECR FAQ
What was Eurofins-Cerep SA’s price range in the past 12 months?
Eurofins-Cerep SA lowest stock price was €10000.00 and its highest was €26800.00 in the past 12 months.
What is Eurofins-Cerep SA’s market cap?
Eurofins-Cerep SA’s market cap is €89.80M.
When is Eurofins-Cerep SA’s upcoming earnings report date?
Eurofins-Cerep SA’s upcoming earnings report date is Apr 09, 2026 which is in 101 days.
How were Eurofins-Cerep SA’s earnings last quarter?
Eurofins-Cerep SA released its earnings results on Sep 18, 2025. The company reported €360.825 earnings per share for the quarter, beating the consensus estimate of N/A by €360.825.
Is Eurofins-Cerep SA overvalued?
According to Wall Street analysts Eurofins-Cerep SA’s price is currently Overvalued.
Does Eurofins-Cerep SA pay dividends?
Eurofins-Cerep SA does not currently pay dividends.
What is Eurofins-Cerep SA’s EPS estimate?
Eurofins-Cerep SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eurofins-Cerep SA have?
Eurofins-Cerep SA has 5,045 shares outstanding.
What happened to Eurofins-Cerep SA’s price movement after its last earnings report?
Eurofins-Cerep SA reported an EPS of €360.825 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Eurofins-Cerep SA?
Currently, no hedge funds are holding shares in FR:ALECR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eurofins-Cerep SA
Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.
Technical Analysis
Innate Pharma SA
―
Eurofins Scientific
―
OSE Immunotherapeutics SA
―
Lumibird SA
―
Sensorion SAS
―